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Objective: to evaluate the role of a combined percutaneous endovascular approach including thrombus aspiration, catheter
thrombolysis, and percutaneous transluminal angioplasty (PTA) to treat acute and subacute occlusions of native leg
arteries.
Materials and methods: retrospective evaluation of the effectiveness and safety of this catheter therapy in 89 consecutive
patients (93 legs) in a single centre.
Results: treatment was initially successful in 90% of legs. Mortality at 30 days was 8%, and at 12 months 19%.
Amputation-free survival at 12 months was 78%. Aspiration alone was sufficient in 31% of cases, urokinase (mean dose
112 500±55 900 IU) was used in 22%, PTA was added in 69%. There was no major bleeding except for one false
aneurysm treated by ultrasound-guided compression. Secondary interventions within 12 months were required in 30%
of cases (14 endovascular, 16 open surgical procedures).
Conclusions: catheter thrombus aspiration in combination with thrombolysis and/or PTA is highly effective. Only in a
minority of patients are thrombolytics in modest doses necessary, and serious bleeding complications are rare. We
recommend this procedure as first-line treatment for acute or subacute infrainguinal arterial occlusions.
Key Words: Percutaneous catheter thrombus aspiration; Thrombolysis; PTA; Endovascular technique; Amputation-free
survival.
Introduction by performing a combined percutaneous endovascular
therapy including catheter aspiration, thrombolysis,
Percutaneous, catheter-directed thrombolysis has been and percutaneous angioplasty (PTA), high rates of
primary success and limb preservation can be achieved.applied for many years to treat acute arterial occlusions
of the legs.1–8 However, the safety and efficacy of the If thrombus aspiration works, thrombolysis may be
avoided altogether or reduced. Because we applyprocedure has continued to give cause for concern.
For example, in the TOPAS trial,9 serious bleeding thrombolysis, when necessary, by thrombus in-
filtration, the doses of urokinase may be minimised, andproblems were associated with local thrombolysis,
although the patency rates did not exceed those the duration of the intervention shortened. Underlying
stenoses detected in the course of the intervention mayachieved by surgery5. Furthermore, in the studies re-
ported hitherto, blood flow is restored more slowly be treated by balloon angioplasty (PTA) in the same
session. The fact that there are only very few pub-than by immediate surgical revascularisation, and tis-
sue ischaemia may progress to necrosis before throm- lications on percutaneous catheter thrombus aspira-
tion,10–12 and even less on this combined approach,10 maybolysis has become effective. Therefore, the
requirements for an ideal catheter-directed method explain why the impact of this procedure has so far not
been widely recognised.must envisage the avoidance of haemorrhage together
with a substantial reduction of the time necessary for
restoring arterial flow comparable to the duration of Methods and Patients
a surgical procedure.
It is the aim of the present study to demonstrate that, Patient selection
There were 89 consecutive patients (42 men and 47∗ Please address all correspondence to: F. Mahler, Division of An-
giology, Inselspital, CH-3010 Bern, Switzerland. women), ages ranging from 29 years to 100 years
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Table 1. General baseline characteristics of patients. Table 2. Vascular baseline characteristics of patients.
Demographics Clinical presentation
Duration of symptoms (days) 6.2 (±7.3)Age (years±SD) 70.7 (±14.9)
Number of patients 89 Pain at rest 89 (100%)
Motor loss 7 (7.7%)Gender
Male 42 Sensory loss 73 (81%)
Embolism likely 53 (61.7%)Women 47
Acute on chronic occlusive disease 40 (49%)Risk factors
History of smoking 39 (44%) Site of arterial occlusion
Aa. fem. sup. et poplitea 24Diabetes 14 (16%)
Hypertension 49 (56%) Aa. fem. sup., poplitea et crurales 32
Aa. crurales 26Hypercholesterolaemia 17 (19%)
Aa. profunda fem., fem. sup. et poplitea 9Co-morbidity
A. profunda femoris 2Cardiopathy 45 (50.5%)
A. fem. sup. 1Coronary heart disease 41 (46.5%)
Atrial fibrillation 19 (21.5%)
Transient cerebral ischaemia or stroke 14 (16%)
Chronic obstructive pulmonary disease 11 (12.5%)
Pulmonary embolism 9 (10%)
Multifocal arterial embolism 7 (8%)
Renal insufficiency 9 (10%)
Total number of patients with co-morbidity 68 (76%)
(mean age 70.7±14.9 years, 93 legs) with acute or
subacute thromboembolic occlusion of native femoro-
popliteal and crural arteries in 93 legs. They constituted
9% of the patients undergoing catheter therapy in
infrainguinal arteries at our institution between Jan-
uary 1995 and May 1997. The indication for catheter
therapy was critical ischaemia in all (69 patients pre-
senting with rest pain, and a further 20 patients with
trophic lesions as well). Treatment decisions were
reached through joint discussions between the vascular
surgeons, the interventional radiologists and an-
giologists.
In this study only patients with occlusions of the
Fig. 1. Acute embolic occlusion of the popliteal and crural arteriesinfrainguinal native arteries were included. before (left panel) and after catheter thrombus aspiration (right
Catheter therapy was performed urgently (the same panel) as the only interventional method applied.
day or within 24 h of onset of symptoms) in 33 cases
(37.5%), whilst in 45 patients (51%) the acute onset of
therapy in 29 legs (31%), all of which had embolicarterial occlusion was less than 14 days. In the re-
occlusion (Fig. 1). In 44 legs (47%) thrombus aspirationmaining 11 patients (12.5%) the acute episode of oc-
was followed by balloon angioplasty (PTA) of under-clusive disease was more than 14 days old (range
lying atherosclerotic lesions without thrombolysis, and14–28 days). For the whole group the mean duration
in only 20 legs (22%) was it necessary to use throm-between onset of the acute occlusive episode and
bolysis together with aspiration and PTA (Fig. 2).catheter therapy was 6.2 days (±7.3). A sensory deficit
Intravenous heparin was given for at least 24 h.was present in 73 patients, and a motor deficit in seven
Thereafter oral anticoagulation was prescribed for 6cases. Twenty legs in patients either with a longer
months in patients with embolism and in those withhistory than 14 days or with subacute or acute-on-
local thrombosis. This was followed by platelet in-chronic disease presented with trophic lesions (21.5%).
hibitors.Baseline patient characteristics and clinical pre-
sentation are shown in Tables 1 and 2.
Procedures Catheter techniques
Percutaneous thrombus aspiration was performed as Under local anaesthesia, after anterograde puncture
catheterisation of the common femoral artery, a 6- orthe primary procedure in all patients and as single
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Control angiography was performed to confirm free
peripheral outflow; underlying stenotic lesions were
thereafter treated by PTA in the same session. Com-
pletion angiography was performed before removal
of all instruments. Duration of the intervention and
total dose of the lytic agents were recorded.
Outcome criteria
Endpoints of the present study were mortality, am-
putation at 30 days, 6 and 12 months and the am-
putation-free survival of the entire patient group at 6
and 12 months. Other endpoints were the primary
dissolution of occluding thrombus, i.e. primary success
and patency rate achieved by the afore-mentioned
catheter techniques, and the number and percentage
of secondary reinterventions necessary, whether open
surgical or by catheter technique. Surgical re-
interventions consisted of femorodistal bypasses orFig. 2. Demonstration of the combination of thrombolytic therapy
with catheter thrombus aspiration. Left panel: Acute occlusion of thromboendarterectomy, catheter reinterventions in-
the popliteal trifurcation with motor and sensory deficit, one day cluded repeated thrombus aspiration with and without
old. Middle panel: After 20 min of intraclot thrombolysis with
adjuvant lytic therapy and PTA, with placement of aurokinase (60 000 IU) there was only minor improvement but throm-
bus aspiration was possible. Right panel: By percutaneous catheter stent in one single instance.
thrombus aspiration complete restoration of patency was achieved With regard to the occurrence of adverse effects of
within 15 min.
lytic therapy, special attention was given to bleeding
complications, including cerebral haemorrhage with
8F introducer sheath with a removable haemostatic or without associated mortality. The individual doses
valve was introduced.10,11 A bolus of 5000 IU of heparin of urokinase used were recorded and related to pos-
was given. In the presence of fresh thromboembolic sible complications. False aneurysms were also sought.
material a thin-walled 6–8F aspiration catheter with The observation time was 12 months. Two patients
an end-hole was positioned into the proximal end of with successful catheter treatment were returned to
the thrombus, whereupon the aspiration was per- their referring hospital on the same day, whereupon
formed with a 60-ml syringe. For the extraction of they were lost to follow-up (three legs). The follow-
larger pieces of clot, the haemostatic valve had to be up of 12 months in this study is therefore based on
removed. By repeating clot extraction all the non- 87 patients and 90 legs, respectively.
adherent material could be removed, whilst residual
thrombotic material adhering to the vessel wall was
loosened with an angioplasty balloon or with a wire Statistical analysis
loop11,12 and subsequently also sucked out. In the crural
arteries 5F aspiration catheters were used. If it was Quantitative data were expressed as mean values±one
impossible to remove the occluding clot completely, standard deviation.
then local catheter thrombolyis was performed in the Times to events were analysed with Kaplan–Meier
same session. A 0.035-inch guidewire served to in- analysis (Stata, Release 5, Stata Corporation, College
troduce a microporous balloon catheter (Schneider R) station Texas, 1997). Group differences were assessed
down into the proximal part of the thrombus, taking with the unpaired Student’s t-test, and with Mann–
care not to pass beyond the clot in order to avoid Whitney U-test for non-parametric groups. A p-value
peripheral embolism. Through the balloon catheter, less than 0.05 was considered significant.
urokinase was infiltrated into the thrombus (dosage
10 000–20 000 units per cm of occlusion length). Under
fluoroscopic control, the balloon catheter was for- Results and Clinical Outcome
warded centimetre by centimetre until the distal end
of the thrombus was reached. Clot material loosened A summary of the results including primary success,
secondary procedures, amputations, and mortality isby partial lysis was removed by repeated aspiration.
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Table 3. Results of catheter interventions.
n %
Procedures: 93 100
Aspiration only 29 31
Thrombolysis 20 22
PTA 64 69
Primary success 84 90
Secondary procedures 28 30
Endovascular 14
Surgical 16
Amputations (6 m) 8 9
Below-knee 5
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Above-knee 2 Fig. 4. Kaplan–Meier curve showing 12 month amputation-free
survival of the whole patient group.Mortality
30 days 8
6 months 16
12 months 19 The amputation-free survival at 6 and 12 months is
illustrated in Figure 4.
Whilst for the entire group of 89 patients the acute
thrombotic or embolic occlusion of the leg had oc-
curred within 6.2±7.3 days, the arterial occlusion
event in 19 patients (20 legs) requiring adjunctive
thrombolysis was older (11.15±9.8 days; p<0.01). In
the 70 patients who did not need thrombolysis (70
patients) the duration of symptoms before treatment
was even shorter (4.7±5.6 days; Mann–Whitney U-
test: p=0.0045).
Discussion
The analysis of the efficacy and safety of percutaneous
catheter thrombus aspiration in combination with ad-
junct thrombolysis and/or PTA of 93 legs in 89 patients
0
0.5
Techniques
0.4
0.3
0.2
0.1
shows an initial treatment success in 90% of the legs,
Fig. 3. Percutaneous catheter thrombus aspiration was performed a reintervention rate of 30%, an amputation-free sur-in all patients in this series of 93 legs. It was the single therapy in
vival in 78%, and a mortality rate of 19% at 12 months’31%, and was combined with adjunctive PTA in 47%. In 22% only
(white bar) it was necessary to add modest doses of urokinase that follow-up. These results were accomplished by as-
gave rise to clot disintegration and facilitated clot aspiration. (;) piration alone in 31%, by additional thrombolysis inAspiration alone; (Ε) aspiration+PTA; (Φ) aspiration+PTA+lysis.
22%, and by PTA in 69% of the treated legs.
The TOPAS trial, a randomised prospective study
comparing local thrombolysis to open surgery re-
ported by Ouriel and associates,9 demonstrated that
thrombolysis reduced the need for secondary open-given in Table 3. Application of catheter aspiration
alone without additional lysis or PTA, of adjunct surgery procedures. Whereas in the TOPAS study
25% of all occlusions were located above the inguinalthrombolytic therapy, and PTA is illustrated in Fig. 3.
The individual doses of urokinase varied between ligament, and thrombolysis was used for bypass grafts
in 55%, the occlusions in our study were all limited to50 000 and 250 000 IU (mean 112 500±55 900 IU). There
were no major bleeding episodes, with the exception infrainguinal native arteries. The majority of occlusions
affected the distal femoropopliteal axis and the cruralof one false aneurysm at a puncture site which was
treated successfully by ultrasound-guided com- arteries. The mortality rates in our patients and in
those of the TOPAS study indicate that the populationspression. No blood transfusions were necessary, and
there was no intracranial haemorrhage. Duration of are comparable at least with respect to their general
co-morbidity.the intervention ranged between 35 and 160 min.
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Eight patients (9%) in our series underwent major Dotter14 was the first to recognise the potential of
selective clot lysis with low-dose streptokinase. Im-amputation, six below-knee, two above-knee, and one
provement of local lytic treatment was sought bythrough-knee. In the TOPAS study the amputation-free
infiltrating the thrombus directly using an end-holesurvival rates in patients treated with urokinase were
catheter by Hess1,2 rather than by perfusing the ex-comparable to those achieved in the group with surgical
tremity with the thrombolytics. Schneider10 used thetreatment. However, there were 58 major amputations
microporous baloon catheter as applied in this study.in the urokinase group (21%), 33 below-knee, and 25
Newer approaches are the pulsed or intraclot sprayabove-knee. Thus, the percentage of amputees in the
techniques.15,16 All these techniques allow a reductionTOPAS study is significantly larger than in our series
in the dose and time of thrombolysis. Schneider,10 and(p<0.05). The higher proportion of above-knee am-
later Starck et al.11 demonstrated that percutaneousputations (p=0.01) may be related to the more proximal
catheter clot aspiration and extraction were feasible,disease. The 6 months amputation-free survival rate
and a valuable addition to the armament of catheterin our study was 82%, the 12 months amputation-free
therapy. By aspirating much, if not all, of the occludingsurvival 78% (Fig. 4). In another prospective ran-
clot the necessary dosage of lytic agent will be reduceddomised study by Ouriel et al.,6 the Rochester trial, the
significantly, and in fact render such medication un-amputation-free survival rates at 1 year were 75% for
necessary in a majority of cases. Thrombolysis servesthe patients assigned to thrombolysis with urokinase,
rather to facilitate clot aspiration than to dissolve theand 52% for those assigned to surgical treatment. Whilst
whole volume of thrombus, and conversely per-the figures on local thrombolysis are similar in this re-
cutaneous clot removal decreases the dose of uro-port to our study with respect to the efficacy, there is a
kinase. The end result is not only a reduction of thehighly significant difference with regard to safety.
amount of thrombolytics but also of the time necessaryThe mean dose of urokinase in the TOPAS study was
to obtain patency, ranging from 35 to 160 min. The3.5±1.8 millions IU, the mean duration of urokinase
procedure is thus performed within the same timeinfusion 24.4±14.2 h. In our study, the mean dose of
limits as a surgical intervention.The shorter duration ofurokinase was only 112 500±55 900 IU. In the TOPAS
aspiration and adjunct interventions and the reducedstudy, there was a 12.5% major bleeding rate in the
exposure to thrombolytic agents are the factors weurokinase group, which increased further when
consider responsible for the lower rate of serious com-patients received heparin. In four cases these haem-
plications.orrhages were intracranial, and in one case fatal. The
In conclusion, because of these advantages we re-concomitant use of heparin had to be restricted during
commend the combined catheter approach describedthe course of the study. Transfusions of more than one above as first-line treatment for the segment of patients
unit of packed red cells were necessary in 92 patients with acute or subacute occlusions in infrainguinal
(33.8%) in the urokinase group of the TOPAS study. arteries. The intervention proposed in this series allows
This has been critically commented on in the ac- for clot aspiration, mild thrombolysis, and PTA as
companying editorial.13 Also, the Rochester study6 re- an ‘‘all-in-one’’ procedure, and is performed in local
ported an 11% rate of serious bleeding complications anaesthesia. Only a minority of cases will need modest
in patients receiving urokinase, with one death due to amounts of lytic agents to obtain vascular patency.
haemorrhage. The STILE study5 reported a 5.6% rate Hospitalisation time is reduced and patient comfort
of serious haemorrhages in patients receiving throm- considerably enhanced.
bolytic agents, with low fibrinogen values identified
as a risk factor. As stated earlier, there were no major
haemorrhages in our study, accordingly no trans-
fusions, and no surgical interventions for bleeding Acknowledgements
complications were necessary.
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